Clinical Trial Screening in Gynecologic Oncology: Defining the Need and Identifying Best Practices
(Abstracted from Gynecol Oncol 2025;192:111–119 Clinical trial recruitment and enrollment are multifaceted and require careful representation of diverse populations; clinical trials focusing on gynecologic cancer tend to be underfunded compared with other conditions, thus underscoring the need for established best practices when it comes to clinical trial recruitment and enrollment. Screening for clinical trials varies based on site, but many rely on manual processes that are not streamlined or standardized, and which can introduce screening bias.
Authors
- John F. Peppin
- Bhavana Pothuri (ORCID: https://orcid.org/0000-0003-4578-2061)
- Victoria Bae‐Jump (ORCID: https://orcid.org/0000-0001-6778-0951)
- Tara Castellano
- Tashanna Myers (ORCID: https://orcid.org/0000-0002-4770-1408)
- Dana M. Chase (ORCID: https://orcid.org/0000-0002-1073-8688)
- Kathleen N. Moore (ORCID: https://orcid.org/0000-0002-5803-0718)
- Amanda Jackson (ORCID: https://orcid.org/0000-0003-4056-3337)
- S. Ghamande
- Thomas J. Herzog (ORCID: https://orcid.org/0000-0003-3636-1345)
- Olivia D. Lara (ORCID: https://orcid.org/0000-0002-3540-5804)
- C Mccormick
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1097/01.ogx.0001125116.93050.6d
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00